| abstract |
USE OF STIMULANTS OF SOLUBLE GUANILATE CYCLASE (sGC), PHARMACEUTICALLY ACCEPTABLE SALTS OF THE SAME, AND PHARMACEUTICAL FORMULATIONS OR DOSAGE FORMS THAT INCLUDE THE SAME, WHETHER ALONE OR IN COMBINATION OF AGENCIES OR IN COMBINATION OF AGERMO IN COMBINATION, OR IN COMBINATION OF AGERMATE OF THE CNS, WHERE AN INCREASED STIMULATION OF sGC, OR AN INCREASE IN THE CONCENTRATION OF NITRIC OXIDE (NO) OR GUANOSINE 3 ', 5'-CYCLIC MONOPHOSPHATE (GMPc) OR BOTH, OR AN INCREASE IN THE EXPRESSION OF THE WAY OF NO. |